Aspire Biopharma Holdings, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CREWE ADVISORS LLC | 11/13/2025 | 813.43 K | $167.57 K | 29.76% | 1.65% |
| PROCYON ADVISORS, LLC | 10/28/2025 | 472.66 K | $97.37 K | -27.10% | 0.96% |
| VANGUARD GROUP INC | 11/07/2025 | 428.55 K | $88.28 K | 100.00% | 0.87% |
| OPTIVISE ADVISORY SERVICES LLC | 10/17/2025 | 263.52 K | $54.29 K | 12.09% | 0.53% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 250.16 K | $51.53 K | 100.00% | 0.51% |
| ANTARA CAPITAL LP | 11/14/2025 | 202.90 K | $41.80 K | 100.00% | 0.41% |
| 11/12/2025 | 136.17 K | $28.05 K | 100.00% | 0.28% | |
| VR ADVISORY SERVICES LTD | 11/14/2025 | 97.39 K | $20.06 K | 0.00% | 0.20% |
| RESOLUTE ADVISORS LLC | 11/14/2025 | 82.78 K | $17.05 K | 100.00% | 0.17% |
| THREE SEASONS WEALTH, LLC | 10/17/2025 | 75.00 K | $15.45 K | 0.00% | 0.15% |
| P SCHOENFELD ASSET MANAGEMENT LP | 11/14/2025 | 58.56 K | $12.06 K | 100.00% | 0.12% |
| AVION WEALTH | 10/24/2025 | 54.11 K | $11.00 K | 100.00% | 0.11% |
| PERISCOPE CAPITAL INC. | 11/13/2025 | 50.00 K | $10.30 K | -33.33% | 0.10% |
| CIBC PRIVATE WEALTH GROUP, LLC | 11/24/2025 | 49.13 K | $10.12 K | 591.18% | 0.10% |
| HALLMARK CAPITAL MANAGEMENT INC | 11/03/2025 | 40.00 K | $8.24 K | 0.00% | 0.08% |
| PLATFORM TECHNOLOGY PARTNERS | 10/29/2025 | 37.61 K | $7.75 K | 0.00% | 0.08% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2025 | 31.12 K | $6.41 K | 100.00% | 0.06% |
| JANE STREET GROUP, LLC | 11/14/2025 | 29.26 K | $6.03 K | -80.82% | 0.06% |
| XTX TOPCO LTD | 11/14/2025 | 27.85 K | $5.74 K | 100.00% | 0.06% |
| CROSSINGBRIDGE ADVISORS, LLC | 11/13/2025 | 24.35 K | $7.42 K | 100.00% | 0.05% |
| COLONY GROUP, LLC | 11/14/2025 | 12.54 K | $2.58 K | 100.00% | 0.03% |
| ALLRED CAPITAL MANAGEMENT, LLC | 11/13/2025 | 11.19 K | $2.30 K | 0.00% | 0.02% |
| UBS GROUP AG | 11/13/2025 | 7.66 K | $1.58 K | 100.00% | 0.02% |
| SOA WEALTH ADVISORS, LLC. | 10/21/2025 | 2.92 K | $602 | 100.00% | 0.01% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 253 | $52 | -6.64% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/14/2025 | 100 | $20 | 0.00% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
| SCIENTECH RESEARCH LLC | 11/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aspire Biopharma Holdings, Inc. institutional Ownership - FAQ's
During the previous two years, 21 institutional investors and hedge funds held shares of Aspire Biopharma Holdings, Inc.. The most heavily invested institutionals were:
SOA Wealth Advisors, LLC.: 0
GEODE CAPITAL MANAGEMENT, LLC: 250,161
Antara Capital LP: 202,897
VR Advisory Services Ltd: 97,391
Resolute Advisors LLC: 82,783
P SCHOENFELD ASSET MANAGEMENT LP: 58,563
6.61% of Aspire Biopharma Holdings, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.01 M shares in the last 24 months. This purchase volume represents approximately $2.15 M in transactions.